Diane C. Young
2021 - Celldex Therapeutics
In 2021, Diane C. Young earned a total compensation of $2.2M as Senior Vice President, Chief Medical Officer at Celldex Therapeutics.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Option Awards | $1,564,970 |
| Salary | $430,163 |
| Other | $5,834 |
| Total | $2,200,967 |
Young received $1.6M in option awards, accounting for 71% of the total pay in 2021.
Young also received $200K in bonus, $430.2K in salary and $5.8K in other compensation.
Rankings
In 2021, Diane C. Young's compensation ranked 5,681st out of 12,406 executives tracked by ExecPay. In other words, Young earned more than 54.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,681 out of 12,406 | 54th |
Division Manufacturing | 2,411 out of 5,492 | 56th |
Major group Chemicals And Allied Products | 1,046 out of 2,368 | 56th |
Industry group Drugs | 933 out of 2,089 | 55th |
Industry In Vitro and In Vivo Diagnostic Substances | 21 out of 61 | 66th |
Pay ratio
| Diane C. Young's Pay | $2,200,967 |
|---|---|
| Median Employee's Pay | $195,006 |
| Pay Ratio | 11to 1 |
In 2021, the annual total compensation of Diane C. Young was $2,200,967.
The annual total compensation of the median employee at Celldex Therapeutics was $195,006.
The ratio of Diane C. Young's pay to the pay of median employee was therefore 11 to one.
Source: SEC filing on April 26, 2022.
Young's colleagues
We found four more compensation records of executives who worked with Diane C. Young at Celldex Therapeutics in 2021.